Article Information
History
- February 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sabrina E. Racine-Brzostek1,2,
- Mohsen Karbaschi3,
- Christian Gaebler4,
- P.J. Klasse5,
- Jim Yee1,2,
- Marina Caskey4,
- He S. Yang1,2,
- Ying Hao1,6,
- Amy Chadburn1,2,
- Yuanyuan Shi6,7,
- Robert Zuk3,
- Michel C. Nussenzweig4,8,
- Melissa M. Cushing1,2 and
- Zhen Zhao1,2,†
- 1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
- 2NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA
- 3ET HealthCare, Palo Alto, CA, USA
- 4Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA
- 5Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA
- 6School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
- 7Department of Biomedical Engineering, Shenzhen Research Institute, Beijing University of Chinese Medicine, Shenzhen, Guangdong, China
- 8Howard Hughes Medical Institute
- ↵†Address correspondence to this author at: Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, Suite F-701 New York, NY 10065. (Telephone) 212-746-2682 Fax (212) 746-8855; zhz9010{at}med.cornell.edu
Posted February 08, 2021.
TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability
